US Patent 11185594 (Anti-HER2 antibody)-drug conjugate
Patent 11185594 was granted and assigned to Daiichi Sankyo on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+603 characters)
Article
Patent abstract
As an antitumor drug which is excellent in terms of antitumor effect and safety and has an excellent therapeutic effect, there is provided an antibody-drug conjugate in which an antitumor compound represented by the following formula is conjugated to an anti-HER2 antibody via a linker having a structure represented by the formula: L1-L2-LP-NH—(CH2)n1-La-Lb-Lc or -L1-L2-LP- wherein the anti-HER2 antibody is connected to the terminal L1, and the antitumor compound is connected to the terminal Lc or LP with the nitrogen atom of the amino group at position 1 as the connecting position.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111855940
Date of Patent
November 30, 2021
0Patent Application Number
153028030
Date Filed
April 6, 2015
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111855940
Date of Patent
November 30, 2021
0Patent Application Number
153028030
Date Filed
April 6, 2015
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11185594 (Anti-HER2 antibody)-drug conjugate
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11185594
Date of patent
November 30, 2021
Patent application number
15302803
Date Filed
April 6, 2015
Patent primary examiner
Find more entities like US Patent 11185594 (Anti-HER2 antibody)-drug conjugate
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
